Silvia De Siervi

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling.

Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling.

Journal: Bio-protocol

Published: November 19, 2025

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Journal: British journal of cancer

Published: June 26, 2025

Erratum: VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference.

Erratum: VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference.

Journal: iScience

Published: April 14, 2025

From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation.

From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 04, 2025

PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD).

PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD).

Journal: Journal of translational medicine

Published: August 03, 2024

VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference.

VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference.

Journal: iScience

Published: November 23, 2023

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

Journal: Molecular metabolism

Published: October 27, 2023

Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment.

Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment.

Journal: International journal of molecular sciences

Published: June 01, 2023

Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.

Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.

Journal: International journal of molecular sciences

Published: February 01, 2023

Characterization of Mitochondrial Alterations in Aicardi-Goutières Patients Mutated in RNASEH2A and RNASEH2B Genes.

Characterization of Mitochondrial Alterations in Aicardi-Goutières Patients Mutated in RNASEH2A and RNASEH2B Genes.

Journal: International journal of molecular sciences

Published: October 28, 2022

SerpinB3 administration protects liver against ischemia-reperfusion injury.

SerpinB3 administration protects liver against ischemia-reperfusion injury.

Journal: European journal of histochemistry : EJH

Published: September 21, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026